BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4738316)

  • 1. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. I. Activation by tuberculin and by Staphylococcus filtrate.
    Stejskal V; Holm G; Perlmann P
    Cell Immunol; 1973 Jul; 8(1):71-81. PubMed ID: 4738316
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. II. Activation by phytohemagglutinin.
    Stejskal V; Lindberg S; Holm G; Perlmann P
    Cell Immunol; 1973 Jul; 8(1):82-92. PubMed ID: 4199809
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. IV. Competitive inhibition of target cell lysis by addition of unlabeled cells.
    Stejskal V
    Scand J Immunol; 1976; 5(5):479-86. PubMed ID: 822508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergystic action of sera from transplant recipients and lymphocytes activated in vitro.
    Gordon J; MacDonald H; MacLean LD
    Transplant Proc; 1973 Mar; 5(1):429-31. PubMed ID: 4695951
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum-mediated immunological non-reactivity between histoincompatible cells in tetraparental mice.
    Phillips SM; Martin WJ; Shaw AR; Wegmann TG
    Nature; 1971 Nov; 234(5325):146-8. PubMed ID: 4942675
    [No Abstract]   [Full Text] [Related]  

  • 6. Target cell lysis mediated by soluble cytotoxin released from stimulated lymphocytes.
    Peter JB; Dawkins RL
    Nat New Biol; 1971 Jul; 232(29):79-80. PubMed ID: 5285342
    [No Abstract]   [Full Text] [Related]  

  • 7. T-cell mediated immunity in vitro: an analysis of antigen recognition and target cell lysis.
    Feldman M; Cohen IR; Wekerle H
    Transplant Rev; 1972; 12():57-90. PubMed ID: 4119632
    [No Abstract]   [Full Text] [Related]  

  • 8. Morphological changes in normal lymphocytes treated with phytohemagglutinin and methotrexate following their interaction with target cells.
    Bykovskaya SN; Slavina EG; Kadagidze ZG; Chernyakhovskaya IYu
    Bull Exp Biol Med; 1974 Oct; 77(4):421-4. PubMed ID: 4425745
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. III. Species specificity of lymphocyte target cell recognition in vitro.
    Stejskal V; Perlmann P
    Eur J Immunol; 1976 May; 6(5):347-52. PubMed ID: 991906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytotoxicity of human lymphocytes: reduction of the lymphocyte cytotoxicity induced by antibodies or phytohemagglutinin by removing immune-complex-binding cells.
    Hallberg T
    Scand J Immunol; 1974; 3(5):645-54. PubMed ID: 4138557
    [No Abstract]   [Full Text] [Related]  

  • 11. Unmasking of xenogeneic neo-antigens on mouse lymphoid cell surfaces by Vibrio cholerae neuraminidase.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):217-22. PubMed ID: 4118961
    [No Abstract]   [Full Text] [Related]  

  • 12. The cytolytic activity of human lymphocytes. I. Cytolytic activity towards PPD-coated target cells in tuberculin positive and negative individuals.
    Rehn TG; Henney CS
    Johns Hopkins Med J; 1972 Oct; 131(4):261-70. PubMed ID: 5081728
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenic RNA in the immunotherapy of cancer: the transfer of antitumor cytotoxic activity and tuberculin sensitivity to human lymphocytes using xenogeneic ribonucleic acid.
    Dodd MC; Scheetz ME; Rossio JL
    Ann N Y Acad Sci; 1973 May; 207():454-67. PubMed ID: 4517721
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cellular mechanisms of immunologic facilitation. Study of 2 models in vitro].
    Fontaine J; Oppenheim SE; Voisin GA
    C R Acad Hebd Seances Acad Sci D; 1972 Apr; 274(16):2404-7. PubMed ID: 4624978
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between the beta-2-m-HL-A molecule and membrane structures responsible for lymphocyte activation.
    Solheim BG
    Transplant Rev; 1974; 21(0):35-52. PubMed ID: 4139788
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin.
    Kolb WP; Granger GA
    Cell Immunol; 1970 May; 1(1):122-32. PubMed ID: 5535593
    [No Abstract]   [Full Text] [Related]  

  • 17. Allogeneic inhibition in tolerant animals.
    Möller E; Lapp W; Lindholm L
    Transplant Proc; 1969 Mar; 1(1):543-7. PubMed ID: 4944269
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-mediated immune reactions in vitro: cytotoxicity of lymphocytes activated by phytohemagglutinin and anti-immunoglobulin serum.
    Resch K; Fischer H
    Eur J Immunol; 1971 Aug; 1(4):271-5. PubMed ID: 5316633
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of neuraminidase to unmask allogeneic antigens on cell surfaces.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):600-4. PubMed ID: 5118473
    [No Abstract]   [Full Text] [Related]  

  • 20. The lysis of fibroblasts by lymphocytes sensitized in vitro: specific antigen activates a nonspecific effect.
    Cohen IR; Feldman M
    Cell Immunol; 1970 Nov; 1(5):521-35. PubMed ID: 4108697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.